METRONIDAZOL 5 MG/ML SOL INFUS IV ENV AL BOLS PLAS PEBD TRANS SIST FECH X 100 ML

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1031101540014
  • GGREM 511219010036616
  • Código de barras 7898361700287

O que a fonte publica

Detentor do registro
HALEX ISTAR INDUSTRIA FARMACEUTICA SA
Princípios ativos
METRONIDAZOL
Embalagem
5 MG/ML SOL INFUS IV ENV AL BOLS PLAS PEBD TRANS SIST FECH X 100 ML
Tipo de produto
Genérico
Classe terapêutica
J8B - OUTROS ANTIINFECCIOSOS ANAERÓBICOS

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:511219010036616
{
  "name": "METRONIDAZOL 5 MG/ML SOL INFUS IV ENV AL BOLS PLAS PEBD TRANS SIST FECH X 100 ML",
  "holder": "HALEX ISTAR INDUSTRIA FARMACEUTICA SA",
  "stripe": null,
  "barcodes": [
    "7898361700287"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "511219010036616",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "01.571.702/0001-98",
  "priceRegime": "Regulado",
  "productName": "METRONIDAZOL",
  "productType": "Genérico",
  "hospitalOnly": true,
  "presentation": "5 MG/ML SOL INFUS IV ENV AL BOLS PLAS PEBD TRANS SIST FECH X 100 ML",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "13.31",
    "icms-12": "15.13",
    "icms-17": "16.04",
    "icms-18": "16.23",
    "icms-19": "16.43",
    "icms-20": "16.64",
    "icms-21": "16.85",
    "icms-22": "17.06",
    "icms-23": "17.29",
    "icms-17.5": "16.13",
    "icms-19.5": "16.53",
    "icms-20.5": "16.74",
    "icms-22.5": "17.17",
    "icms-12-alc": "14.94",
    "icms-17-alc": "15.84",
    "icms-18-alc": "16.04",
    "icms-19-alc": "16.23",
    "icms-20-alc": "16.44",
    "icms-21-alc": "16.65",
    "icms-22-alc": "16.86",
    "icms-23-alc": "17.08",
    "withoutTaxes": "13.15",
    "icms-17.5-alc": "15.94",
    "icms-19.5-alc": "16.34",
    "icms-20.5-alc": "16.54",
    "icms-22.5-alc": "16.97"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "METRONIDAZOL",
  "targetSpecies": [],
  "consumerPrices": null,
  "invalidBarcodes": [],
  "activeSubstances": [
    "METRONIDAZOL"
  ],
  "therapeuticClass": "J8B - OUTROS ANTIINFECCIOSOS ANAERÓBICOS",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1031101540014",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "J8B",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:511219010036616"